Gerard Eberl

Gerard Eberl serves as Professor at Institut Pasteur, Head of the Microenvironment & Immunity Unit, Director of INSERM U1224, and Chair of the Department of Immunology. His career spans prestigious institutions including Rockefeller University, New York University School of Medicine, and Ludwig Institute for Cancer Research. Eberl maintains active leadership roles in major immunological initiatives and has been recognized internationally for his contributions to understanding immune-microbiome interactions.

Education:

• B.Sc. Biochemistry, University of Lausanne (1990)
• Ph.D. Immunology, University of Lausanne (1996)
• Postdoc, Ludwig Institute for Cancer Research (1996-2000)
• Postdoc, Skirball Institute, New York (2000-2003)
• Habilitation Immunology, Institut Pasteur, University Paris VI (2006)

Eberl's research centers on the dynamic relationship between host immunity and microbiota, particularly in mucosal environments. His work has pioneered understanding of how gut microbiota shapes immune development and function, with special focus on innate lymphoid cells and their role in maintaining intestinal homeostasis. His concept of 'immunity by equilibrium' has transformed how scientists view host-microbe symbiosis, revealing how disruptions in microbial communities contribute to inflammatory diseases. His investigations into gut-brain connectivity and microbiota's influence on neurodegenerative processes represent cutting-edge interdisciplinary work.

Analysis of Eberl's publication record reveals consistent leadership in immunological paradigm shifts, particularly in innate lymphoid cell biology and microbiome-immune crosstalk. His work spans fundamental mechanisms of lymphoid tissue development to clinical implications for inflammatory diseases, with increasing focus on translational applications. The progression from basic lymphoid tissue development to microbiome-brain axis research demonstrates remarkable intellectual range while maintaining core focus on host-microbe symbiosis.

Scientific Recognition:

• EMBO Member (2013)
• Chair Louis Pasteur, Institut Pasteur (2015)
• Breakthrough Award, Kenneth Rainin Foundation (2015)
• Prix Jacques Oudin, French Society of Immunology (2013)
• Multiple foundation awards recognizing microbiome-immunology research

Eberl has secured substantial research funding including the Marie Curie Excellence Grant and Schlumberger Foundation support, enabling his team to establish gnotobiotic facilities through the FLOREPIM project. His mentorship extends through editorial leadership as Associate Editor of Mucosal Immunology and advisory roles for major research initiatives. The Microbiota & Brain initiative he co-coordinates represents a significant institutional investment in his research vision.

As Director of INSERM U1224 and Head of Microenvironment & Immunity Unit, Eberl leads a multidisciplinary team investigating how tissue microenvironments shape immune responses. His laboratory maintains specialized gnotobiotic facilities for microbiome research and collaborates extensively with neuroscientists through the Institut Pasteur's Neurodegenerative Disease priority axis. The unit's work bridges basic immunology with clinical applications in inflammatory and neurodegenerative conditions.